Thrombophilia: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombophilia}} | {{Thrombophilia}} | ||
{{CMG}} {{AE}} [[User:Kashish Goel|Kashish Goel, M.D.]] | {{CMG}} {{AE}} [[User:Kashish Goel|Kashish Goel, M.D.]], {{asiri}} | ||
{{SK}} Hypercoagulability, coagulability, hypercoagulable state; thrombosis risk elevation; thrombotic tendency; prothrombotic state; clotting disorder; | {{SK}} Hypercoagulability, coagulability, hypercoagulable state; thrombosis risk elevation; thrombotic tendency; prothrombotic state; clotting disorder; |
Revision as of 12:36, 19 July 2016
Thrombophilia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Thrombophilia On the Web |
American Roentgen Ray Society Images of Thrombophilia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kashish Goel, M.D., Asiri Ediriwickrema, M.D., M.H.S. [2]
Synonyms and keywords: Hypercoagulability, coagulability, hypercoagulable state; thrombosis risk elevation; thrombotic tendency; prothrombotic state; clotting disorder;
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thrombophilia from Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Studies | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Future or Investigational Therapies | Cost Effectiveness of Therapy